Schedule 13D ownership disclosure

Cyclacel Pharmaceuticals Inc

Security class unavailable · CUSIP: 23254L405

Event date: 2017-11-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
336,747
Percent of class
2.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-17-006929
Form type
SC 13D/A
Filer
Bio Green Med Solution, Inc.
CIK
CIK 1130166
Filed
Nov 22, 2017
Reporting period
Nov 16, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub